Share-based Payment Arrangement, Expense in USD of enGene Holdings Inc. from 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
enGene Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2022 to Q2 2025.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending July 31, 2025 was $2.58M, a 76.8% increase year-over-year.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending July 31, 2025 was $8.7M, a 23.8% increase year-over-year.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.32M, a 54.3% increase from 2023.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.45M, a 2874% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

enGene Holdings Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $8.7M $2.58M +$1.12M +76.8% May 1, 2025 Jul 31, 2025 10-Q 2025-09-11
Q1 2025 $7.58M $2.65M +$733K +38.2% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-12
Q4 2024 $6.84M $1.81M +$1.52M +522% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-10
Q3 2024 $5.32M $1.66M -$1.7M -50.6% Aug 1, 2024 Oct 31, 2024 10-K 2024-12-19
Q2 2024 $7.02M $1.46M +$1.42M +3846% May 1, 2024 Jul 31, 2024 10-Q 2025-09-11
Q1 2024 $5.6M $1.92M +$1.88M +4815% Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-12
Q4 2023 $3.72M $291K +$271K +1355% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-10
Q3 2023 $3.45M $3.35M Aug 1, 2023 Oct 31, 2023 10-K 2024-12-19
Q2 2023 $37K May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 $39K Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $20K Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11

enGene Holdings Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.32M +$1.87M +54.3% Nov 1, 2023 Oct 31, 2024 10-K 2024-12-19
2023 $3.45M +$3.33M +2874% Nov 1, 2022 Oct 31, 2023 10-K 2024-12-19
2022 $116K Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.